Finding new ways to save and sustain patients' lives is our passion and commitment. That's why we developed the Baxter BioScience Grants program. By providing an informational guide to assist investigators, educators, and patient organizations in submitting grant applications for funding, we are encouraging creative participation and collaboration in developing an expansive body of scientific knowledge related to our therapies. Together we can make a difference.
Created as a partnership between Baxter Corporation and the Association of Hemophilia Clinic Directors of Canada, the Baxter Canadian Hemophilia Epidemiological Research Program (B-CHERP) Grant provides Canadian investigators and hemophilia clinic directors resources to conduct quality population-based clinical research in hereditary bleeding disorders in Canada.
Through its support of the RENAL DISCOVERIES Extramural Grant Program, Baxter aims to stimulate scientific advancement and general knowledge in nephrology with the goal of improving the quality of life and reducing mortality of patients with kidney disease.